UPDATE : Wednesday, March 27, 2019
상단여백
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo  |  2019-03-08 14:38
라인
17% of hospital workers confirmed with latent tuberculosis
About 17 percent of employees working at local medical institutions were co...
by Kwak Sung-sun  |  2019-03-08 14:36
라인
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo  |  2019-03-07 16:22
라인
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo  |  2019-03-07 16:01
라인
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi  |  2019-03-07 15:52
라인
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon  |  2019-03-07 15:10
라인
Celltrion Healthcare wins biosimilar bids in SE Asia
Celltrion Healthcare said that it won the bids for Singapore’s infliximab b...
by Lee Han-soo  |  2019-03-07 14:25
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo  |  2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im  |  2019-03-07 11:54
라인
SNUBH implements smart surgical system
Seoul National University Bundang Hospital (SNUBH) said that it has built a...
by Lee Han-soo  |  2019-03-06 17:37
라인
Foreign patients mostly satisfied with Korea’s healthcare service
International patients who received treatment at Korean medical institution...
by Lee Han-soo  |  2019-03-06 17:05
라인
Interagency new drug development project generates ₩7.3 trillion license deals
The government said the “pan-governmental full-cycle new drug development p...
by Kwak Sung-sun  |  2019-03-06 16:24
라인
EzCareTech to speed up global presence with IPO
EzCareTech expressed its aspiration to become a global health networking le...
by Lee Han-soo  |  2019-03-06 14:58
라인
Biogen seeks gene therapy pipeline for rare eye disease
The biotech industry is paying attention to whether Biogen’s recent acquisi...
by Kim Yun-mi  |  2019-03-06 14:41
라인
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo  |  2019-03-06 14:27
라인
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo  |  2019-03-06 13:41
라인
Korea to crack down on illegal drugs amid ‘Burning Sun’ scandal
Nine government agencies have set about to crack down on the distribution o...
by Lee Hye-seon  |  2019-03-06 12:27
라인
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer
Samsung Bioepis said Tuesday that the European Medicines Agency has granted...
by Lee Han-soo  |  2019-03-05 17:53
라인
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo  |  2019-03-05 16:22
라인
Jeju Province to nullify approval for for-profit hospital
China’s Greenland Group requested Jeju Province to extend the deadline for ...
by Lee Min-ju  |  2019-03-05 16:22
여백
여백
여백
Back to Top